Deep Learning for Predicting Major Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer: A Multicentre Study

This study, based on multicentre cohorts, aims to utilize computed tomography (CT) images to construct a deep learning model for predicting major pathological response (MPR) to neoadjuvant chemoimmunotherapy in non-small cell lung cancer (NSCLC) and further explore the biological basis under its prediction.